Dermus
Dermus is a Budapest-based medical technology company that develops and sells the SkinScanner-M handheld high-frequency ultrasound device with integrated dermoscopy, plus the SkinAid AI-enabled software platform, serving dermatologists, research institutions, and aesthetic medicine practitioners globally through a distributor network.
- Company typePrivate
- Founded2018
- HeadquartersBudapest, Hungary
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dermus does
Dermus Kft. is a privately held Hungarian medical technology company founded in 2018 as a spin-off of Pázmány Péter Catholic University and headquartered in Budapest. The company develops and commercializes the SkinScanner-M, a handheld high-frequency ultrasound (HFUS) imaging device operating at 20-40 MHz with ≤10 mm depth penetration, integrated with dermoscopy optics providing a 12x12 mm optical field of view — a combination positioned as the first optically-guided ultrasound and the highest-frequency handheld ultrasound in the world. Alongside the hardware, Dermus offers the SkinAid web-based software platform providing AI-based skin layer segmentation, quantification of skin changes, anonymized patient data management, and advanced image annotation with cloud or local storage options, marketed as a research package.
The SkinScanner-M received MDR (CE) Class IIa certification in 2024 under Annex IX of EU Regulation 2017/745 (File# C557072) and the company holds ISO 13485:2016 certification, enabling clinical sales across the EU. Dermus monetizes through hardware sales of the SkinScanner-M and recurring subscription access to the SkinAid platform, with a quote-based, sales-assisted pricing model (no public price disclosure). Go-to-market is exclusively through regional channel partners — 13 active distributors cover approximately 30+ countries across Europe, Asia-Pacific, Middle East, North America, and Africa, targeting dermatologists, skin cancer specialists, medical research institutions, and cosmetic/plastic surgeons. Named reference customers include Mayo Clinic, Hôpital Erasme, Roswell Park Comprehensive Cancer Center, Semmelweis University, and Beiersdorf.
Revenue is not publicly disclosed; total disclosed funding comprises an undisclosed 2019 seed round, a 2021 NKFIH grant of approximately €430,000, and 2022 GINOP venture capital funding of approximately €1.3 million. The company holds a granted US patent (US10928515B2) for data-based scan conversion and has filed a patent for dermoscopy-guided ultrasound imaging technology. Headcount is reported at 1-10 employees, and the company has no parent, subsidiaries, or mergers and acquisitions on record.
Dermus firmographics
Firmographics- Name
- Dermus
- Legal name
- Dermus Kft.
- Website
- https://dermusvision.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Dermus is a Budapest-based medical technology company that develops and sells the SkinScanner-M handheld high-frequency ultrasound device with integrated dermoscopy, plus the SkinAid AI-enabled software platform, serving dermatologists, research institutions, and aesthetic medicine practitioners globally through a distributor network.
- Ownership category
- akta.pro rank
Dermus industry classification
Industry- Product category
- Dermatology Medical Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)
- akta.pro secondary industry
- Procedural Dermatology (Office-Based Surgery) (HLAKACAG)
Keywords
Where Dermus is headquartered
LocationHeadquarters
- HQ city
- Budapest
- HQ country
- Hungary
- HQ region
- Europe
Offices3 records
Markets served
Dermus business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- SkinScanner Hardware Sales: Sale of SkinScanner-M medical device - a handheld high-frequency ultrasound imaging system. Available for clinical use in EU (MDR CE Class IIa). Local regulations vary for pre-clinical, research and aesthetics applications.
- SkinAid Software Platform: Web-based research platform for skin treatment analysis featuring AI-based skin layer segmentation, quantification, patient management with anonymized data collection, cloud or local storage options, advanced filters, settings, and annotation tools.
- Third-Party Image Import: Platform supports third-party image import for broader utility.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | SkinScanner-M (Medical Device) |
Go-to-market motion1 record
Distribution channels12 records
Marketing channels3 records
Dermus product offering
Product offeringCore offering
Dermus develops and sells the SkinScanner-M, a handheld high-frequency ultrasound (20-40 MHz) medical device integrated with dermoscopy optics for evidence-based skin lesion imaging and surgical planning, paired with the SkinAid web-based research platform that provides AI-based skin layer segmentation, quantification, patient management, and image annotation. Both products target dermatologists, skin cancer specialists, medical researchers, and cosmetic surgeons and are sold as MDR (CE) Class IIa certified clinical and research tools through a global distributor network.
Product overview
Dermus offers a unified opto-ultrasound diagnostic system consisting of two integrated components: the SkinScanner-M hardware device and SkinAid software platform. The SkinScanner-M combines high-frequency ultrasound (20-40 MHz) with dermoscopy optics in a handheld form factor, while SkinAid provides AI-powered image analysis, skin layer segmentation, and patient data management. Both products work together for evidence-based skin diagnosis and treatment planning, though they can also function independently.
Differentiator
Problem solved
Functional benefit
Brands
- SkinScanner: High-resolution handheld ultrasound imaging device for evidence-based skin treatments, available as SkinScanner-M with MDR (CE) Class IIa certification
- SkinAid
Products and services
- SkinScanner-M Handheld high-frequency ultrasound (HFUS) imaging device operating at 20-40 MHz with ≤10 mm depth penetration, integrated with dermoscopy optics (12x12 mm optical field of view) for evidence-based skin lesion imaging. Includes 1-D Power Doppler mode, a proprietary image positioning system, and registered industrial design. MDR (CE) Class IIa certified for clinical use in the EU; available for pre-clinical, research, and aesthetics applications subject to local regulations. Designed for dermatologists, dermatologic surgeons, skin cancer specialists, medical researchers, and cosmetic surgeons.
- SkinAid Web-based research platform for evidence-based skin treatment analysis that provides AI-based skin layer segmentation, quantification of skin changes, efficient patient management with anonymized data collection, advanced filters/settings/annotation tools, third-party image import, two-point distance measurement, and volume estimation. Available with cloud or local storage options. Designed for dermatology researchers, skin cancer specialists, and clinical research teams.
Quantifiable outcome
- Superior efficacy for preoperative estimation of Breslow thickness compared to multispectral imaging
- +1 more outcomes
Companies that use Dermus
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Dermus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
Dermus partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Mayo CliniccoreNew collaboration established in 2024 with Mayo Clinic for skin imaging research and clinical validation of Dermus technology.
- Pázmány Péter Catholic UniversitycoreDermus was founded in 2018 as a spin-off company from Pázmány Péter Catholic University, representing the original research foundation for the technology.
- Semmelweis UniversitycoreClinical trial of Dermus SkinScanner device launched at Semmelweis Medical University in 2020, validating the technology in clinical settings.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Dermus competitors and assessment
Company assessmentDirect peers
- Butterfly Network: Butterfly Network manufactures handheld, point-of-care ultrasound devices using a proprietary ultrasound-on-chip technology. Like Dermus, it targets clinician users with portable, affordable imaging hardware, though Butterfly's frequencies and dermatology specificity are lower than Dermus's 20-40 MHz HFUS offering.
- Clarius Mobile Health: Clarius produces high-definition wireless handheld ultrasound scanners for medical professionals. It overlaps with Dermus in offering portable, clinician-targeted ultrasound imaging, with comparable frequencies available in its L7 HD and similar probes for superficial imaging.
- FotoFinder Systems: FotoFinder specializes in dermatology imaging systems including total body photography, dermoscopy, and digital skin analysis used by dermatologists for lesion documentation and AI-assisted assessment. Directly comparable to Dermus as a specialist skin-imaging device vendor for the same clinical customer.
- Canfield Scientific: Canfield Scientific provides medical imaging systems, 3D facial and body capture, and dermatoscopy solutions for dermatology, plastic surgery, and aesthetics. Comparable to Dermus in serving dermatologists and aesthetics practitioners with specialized skin imaging hardware and software.
Emerging players
- Michelson Diagnostics: Michelson Diagnostics develops optical coherence tomography (OCT) and multi-modal imaging devices for skin and other superficial tissue assessment. It overlaps with Dermus in offering high-resolution, non-invasive skin imaging to dermatologists, but uses OCT rather than HFUS.
- Courage+Khazaka electronic: Courage+Khazaka manufactures skin measurement and diagnostic devices (corneometer, sebumeter, etc.) used by dermatologists, cosmeticians, and research institutions. It overlaps with Dermus in the skin analysis device category but focuses on physical property measurement rather than imaging.
Broad incumbents
- Philips Healthcare: Philips is a global incumbent in medical imaging including ultrasound systems across clinical specialties. Its Lumify handheld ultrasound line competes at the edges of Dermus's market, and Philips has the scale to integrate dermatology-specific capabilities if commercially attractive.
- Siemens Healthineers: Siemens Healthineers is a major medical imaging incumbent with a broad ultrasound portfolio serving multiple clinical specialties. Its scale, capital, and installed base in hospitals and clinics make it a structural competitor for any clinical imaging device opportunity Dermus pursues.
- GE HealthCare: GE HealthCare is a leading global medical imaging and ultrasound vendor, including Vscan handheld systems. As a broad incumbent with substantial R&D and commercial resources, it represents both an indirect competitor and a potential strategic acquirer for Dermus's technology.
- Fujifilm SonoSite: SonoSite is an established portable and point-of-care ultrasound manufacturer with broad clinical applications. While not dermatology-specific, its handheld and portable systems compete with Dermus in the POC ultrasound market for clinician users.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Dermus social profiles
Digital presenceDermus compliance and trust
Trust signalCompliance2 records
Dermus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dermus leadership team
Management profileNumber of profiles
Profiles2 records
Dermus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dermus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dermus
What does Dermus do?
Dermus develops and sells the SkinScanner-M, a handheld high-frequency ultrasound (20-40 MHz) medical device integrated with dermoscopy optics for evidence-based skin lesion imaging and surgical planning, paired with the SkinAid web-based research platform that provides AI-based skin layer segmentation, quantification, patient management, and image annotation. Both products target dermatologists, skin cancer specialists, medical researchers, and cosmetic surgeons and are sold as MDR (CE) Class IIa certified clinical and research tools through a global distributor network.
Is Dermus a public or private company?
Dermus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dermus founded?
Dermus was founded in 2018. It employs 1 to 10 people.
Where is Dermus based?
Dermus is headquartered in Budapest, Hungary, in the Europe region.
How does Dermus make money?
Three revenue lines are on record. SkinScanner Hardware Sales are the primary driver. The others are skinAid Software Platform and third-Party Image Import.
Who are Dermus's main competitors?
Direct peers on record are Butterfly Network, Clarius Mobile Health, FotoFinder Systems and Canfield Scientific. Emerging players are Michelson Diagnostics and Courage+Khazaka electronic. Broad incumbents are Philips Healthcare, Siemens Healthineers, GE HealthCare and Fujifilm SonoSite.
Does Dermus have an API?
No public API is recorded for Dermus.
What industry is Dermus in?
Dermus's product category is Dermatology Medical Imaging Devices. Its primary akta.pro industry code is CRABAKAI, Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning), with a secondary code of HLAKACAG, Procedural Dermatology (Office-Based Surgery). Its NAICS code is 334510 and its SIC code is 3845.